C.M. Bidwell & Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
C.M. Bidwell & Associates's IRWD Position: Q3 2026 in Review
C.M. Bidwell & Associates held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2026 at 225 shares worth $893. The position accounts for ﹤0.01% of the portfolio, ranked #438.
C.M. Bidwell & Associates first reported a position in IRWD in Q3 2021 and has held it in 3 quarters since. The position peaked at $83K in Q3 2021. 234 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.
- C.M. Bidwell & Associates held 225 shares of Ironwood Pharmaceuticals worth $893 as of Q3 2026.
- C.M. Bidwell & Associates left its Ironwood Pharmaceuticals share count unchanged in Q3 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q3 2026, its #438 holding.
- C.M. Bidwell & Associates first reported a position in Ironwood Pharmaceuticals in Q3 2021 and has held it in 3 quarters since.
- C.M. Bidwell & Associates's Ironwood Pharmaceuticals position peaked at $83K in Q3 2021.
- 234 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.
Based on C.M. Bidwell & Associates's 13F filing for Q3 2026, filed 17 Nov 2026.